Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The goals of this study are to find out if fat wasting and weight loss in the arms and legs
of HIV patients taking highly active antiretroviral therapy (HAART) are caused by
nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and if wasting can be reversed
if the NRTI is stopped and replaced with other anti-HIV drugs.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)